AR002715A1 - Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados - Google Patents
Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivadosInfo
- Publication number
- AR002715A1 AR002715A1 ARP960101710A AR10171096A AR002715A1 AR 002715 A1 AR002715 A1 AR 002715A1 AR P960101710 A ARP960101710 A AR P960101710A AR 10171096 A AR10171096 A AR 10171096A AR 002715 A1 AR002715 A1 AR 002715A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- preparation
- compounds
- hydrogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Los derivados de la presente invención responden a la fórmula (I), donde G es -CH2- ó -C(O)-; Ar1 es un radical elegido entre fenilo, fenilo substituido,naftilo, naftilo substituido, R1 es hidrógeno, un radical piroglutamoilo, -(CH2)qAr2 ó-CH 2C(O)Ar2; donde q es un número entero de 1 a 4 y Ar2 es unradical fenilo, fenilo substituido o indolilo; R2 es hidrógeno,alquilo C1-C4 ó -CHO; R3 es hidrógeno o un radical seleccionado entre fenilo, fenilosubstituido, naftilo y naftilosubstituido, o sus estereosiómeros o sal farmacéuticamente aceptable. También se describe un intermediario para lapreparación de dichos derivados que responde a la fórmula (2) donde Ar1, R3 y R2 son los antes definidos, siendo R5seleccionado entre hidr ógeno, bencilo oalquilo C1-C4 y R6 entre hidrógeno o -C(O)OR7 donde R7 es bencilo o alquilo C1-C4, y el procedimiento de preparación de dichos derivados. Los derivadosde piperazina y piperazinona son útiles comoantagonistas de los receptores de taquikininas y se aplican en el tratamiento de enfermedades y condicionesmediadas por taquikininas entre las cuales se incluyen: asma, tos y bronquitis. Dichos derivados se incluyen en una composición farmacéuticacon un vehículofarmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40478895A | 1995-03-15 | 1995-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002715A1 true AR002715A1 (es) | 1998-04-29 |
Family
ID=23601038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960101710A AR002715A1 (es) | 1995-03-15 | 1996-03-12 | Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados |
Country Status (21)
Country | Link |
---|---|
US (2) | US5840726A (es) |
EP (1) | EP0815105B1 (es) |
JP (1) | JP3825472B2 (es) |
KR (1) | KR19980703032A (es) |
CN (1) | CN1067068C (es) |
AR (1) | AR002715A1 (es) |
AT (1) | ATE206421T1 (es) |
AU (1) | AU697599B2 (es) |
CA (1) | CA2215333C (es) |
DE (1) | DE69615670T2 (es) |
DK (1) | DK0815105T3 (es) |
ES (1) | ES2164235T3 (es) |
FI (1) | FI973671A (es) |
HU (1) | HUP9702149A3 (es) |
IL (1) | IL117453A (es) |
NO (1) | NO314693B1 (es) |
NZ (1) | NZ302948A (es) |
PT (1) | PT815105E (es) |
TW (1) | TW464647B (es) |
WO (1) | WO1996028441A1 (es) |
ZA (1) | ZA961954B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69621831T2 (de) * | 1995-12-18 | 2003-01-02 | Fujisawa Pharmaceutical Co | Piperazinderivative als tachykinin antagonisten |
DE19939910A1 (de) * | 1999-08-23 | 2001-03-01 | Morphochem Ag | Neue Verbindungen, die Tryptase-Aktivität hemmen |
US7456222B2 (en) * | 2002-05-17 | 2008-11-25 | Sequella, Inc. | Anti tubercular drug: compositions and methods |
US7652039B2 (en) * | 2002-05-17 | 2010-01-26 | Sequella, Inc. | Methods of use and compositions for the diagnosis and treatment of infectious disease |
US20040033986A1 (en) * | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
US7884097B2 (en) * | 2003-09-05 | 2011-02-08 | Sequella, Inc. | Methods and compositions comprising diamines as new anti-tubercular therapeutics |
US20090281054A1 (en) * | 2008-05-06 | 2009-11-12 | Venkata Reddy | Compositions and methods comprising capuramycin analogues |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3132882A1 (de) * | 1981-08-20 | 1983-03-03 | Cassella Ag, 6000 Frankfurt | Neue piperazinone, ihre herstellung und verwendung |
IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
WO1994003483A1 (en) * | 1992-07-30 | 1994-02-17 | Chiron Corporation | Endothelin receptor-binding compounds |
GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
ATE158580T1 (de) * | 1993-05-06 | 1997-10-15 | Merrell Pharma Inc | Substituierte pyrrolidin-3-alkyl-piperidine verwendbar als tachykinin-antagonisten |
IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them |
-
1996
- 1996-02-06 KR KR1019970706440A patent/KR19980703032A/ko not_active Application Discontinuation
- 1996-02-06 DK DK96905333T patent/DK0815105T3/da active
- 1996-02-06 AT AT96905333T patent/ATE206421T1/de not_active IP Right Cessation
- 1996-02-06 JP JP52757896A patent/JP3825472B2/ja not_active Expired - Fee Related
- 1996-02-06 NZ NZ302948A patent/NZ302948A/en unknown
- 1996-02-06 PT PT96905333T patent/PT815105E/pt unknown
- 1996-02-06 CN CN96192564A patent/CN1067068C/zh not_active Expired - Fee Related
- 1996-02-06 EP EP96905333A patent/EP0815105B1/en not_active Expired - Lifetime
- 1996-02-06 CA CA002215333A patent/CA2215333C/en not_active Expired - Fee Related
- 1996-02-06 AU AU49306/96A patent/AU697599B2/en not_active Ceased
- 1996-02-06 HU HU9702149A patent/HUP9702149A3/hu unknown
- 1996-02-06 WO PCT/US1996/001437 patent/WO1996028441A1/en not_active Application Discontinuation
- 1996-02-06 DE DE69615670T patent/DE69615670T2/de not_active Expired - Lifetime
- 1996-02-06 ES ES96905333T patent/ES2164235T3/es not_active Expired - Lifetime
- 1996-03-11 ZA ZA961954A patent/ZA961954B/xx unknown
- 1996-03-12 TW TW085102987A patent/TW464647B/zh active
- 1996-03-12 IL IL11745396A patent/IL117453A/xx not_active IP Right Cessation
- 1996-03-12 AR ARP960101710A patent/AR002715A1/es active IP Right Grant
-
1997
- 1997-06-19 US US08/878,695 patent/US5840726A/en not_active Expired - Lifetime
- 1997-09-12 FI FI973671A patent/FI973671A/fi not_active IP Right Cessation
- 1997-09-12 NO NO19974205A patent/NO314693B1/no unknown
-
1998
- 1998-04-27 US US09/067,386 patent/US5864045A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR19980703032A (ko) | 1998-09-05 |
AU697599B2 (en) | 1998-10-08 |
MX9706872A (es) | 1997-11-29 |
FI973671A0 (fi) | 1997-09-12 |
PT815105E (pt) | 2002-03-28 |
DE69615670D1 (de) | 2001-11-08 |
EP0815105A1 (en) | 1998-01-07 |
JP3825472B2 (ja) | 2006-09-27 |
DK0815105T3 (da) | 2002-01-21 |
WO1996028441A1 (en) | 1996-09-19 |
TW464647B (en) | 2001-11-21 |
ATE206421T1 (de) | 2001-10-15 |
AU4930696A (en) | 1996-10-02 |
ES2164235T3 (es) | 2002-02-16 |
CA2215333C (en) | 2002-01-01 |
US5864045A (en) | 1999-01-26 |
HUP9702149A2 (hu) | 1999-06-28 |
NO974205L (no) | 1997-11-13 |
FI973671A (fi) | 1997-09-12 |
US5840726A (en) | 1998-11-24 |
CN1067068C (zh) | 2001-06-13 |
IL117453A (en) | 2000-07-26 |
NZ302948A (en) | 2001-05-25 |
NO974205D0 (no) | 1997-09-12 |
CN1178529A (zh) | 1998-04-08 |
ZA961954B (en) | 1996-09-17 |
JPH11501917A (ja) | 1999-02-16 |
EP0815105B1 (en) | 2001-10-04 |
IL117453A0 (en) | 1996-07-23 |
DE69615670T2 (de) | 2002-08-08 |
HUP9702149A3 (en) | 1999-07-28 |
CA2215333A1 (en) | 1996-09-19 |
NO314693B1 (no) | 2003-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002986A1 (es) | Nuevos derivados de piperazina sustituida particularmente utiles como antagonistas de receptores de taquiquinina, composiciones farmaceuticas, usosde dichos derivados y procedimiento de preparacion de los mismos. | |
AR035153A1 (es) | Derivados de carboxamidas y cetonas de dihidrobenzodioxina | |
AR041566A1 (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
NO20014951D0 (no) | Substituerte bicykliske heteroarylforbindelser som integrinantagonister | |
AR004516A1 (es) | Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen | |
PT97888A (pt) | Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem | |
AR018634A1 (es) | Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos. | |
ES2137998T3 (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos. | |
DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
CO4970731A1 (es) | Tetrahidro prostaglandinas c16-c29 sustituidas utiles como agonistas fp | |
DK0559756T3 (da) | Nonapeptid-bombesinantagonister | |
ES2174298T3 (es) | Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9302957A (es) | Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
RU94045881A (ru) | Производные пептидов, способ получения, фармацевтическая композиция, способ лечения | |
PE106099A1 (es) | Uso de derivados hidroxicumaranonas sustituidos como agentes antitumorales y antimetastasicos | |
BG94282A (bg) | 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они | |
MX9306310A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
CO4990932A1 (es) | Derivados de 2,1,3-benzotiadiazol y proceso para su preparacion | |
MX9307946A (es) | Derivados de amina secundaria ciclica, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso. | |
AR007108A1 (es) | Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes. | |
AR002715A1 (es) | Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados | |
PE25998A1 (es) | DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS | |
ES2106936T3 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
ECSP034891A (es) | Derivados de benzoxazepina y su uso como estimula_ dores de receptores ampa | |
PT96757A (pt) | Processo de preparacao de derivados de indolo e de composicoes farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |